Aromatase Inhibitors for treatment of metastatic breast cancer

  • Protocol
  • Intervention


  • J Bliss,

  • L Gibson

Ms Judith Bliss, Head, Clinical Trials and Statistics Unit, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey, UK.


This is the protocol for a review and there is no abstract. The objectives are as follows:

This systematic review aims to assess the efficacy of aromatase inhibitors in the treatment of metastatic breast cancer.